LOS ANGELES CAPITAL MANAGEMENT LLC - ALBIREO PHARMA INC ownership

ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 2 filers reported holding ALBIREO PHARMA INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
LOS ANGELES CAPITAL MANAGEMENT LLC ownership history of ALBIREO PHARMA INC
ValueSharesWeighting
Q1 2022$613,000
-8.1%
20,553
-28.2%
0.00%0.0%
Q4 2021$667,000
-25.7%
28,623
-0.6%
0.00%
-50.0%
Q3 2021$898,000
-12.4%
28,790
-1.2%
0.00%
-20.0%
Q2 2021$1,025,000
+3.7%
29,125
+3.9%
0.01%
+25.0%
Q1 2021$988,000
-32.7%
28,035
-28.4%
0.00%
-33.3%
Q4 2020$1,469,000
+110.8%
39,165
+87.5%
0.01%
+100.0%
Q3 2020$697,000
+100.9%
20,890
+59.3%
0.00%
+50.0%
Q2 2020$347,00013,1100.00%
Other shareholders
ALBIREO PHARMA INC shareholders Q3 2023
NameSharesValueWeighting ↓
Prosight Management, LP 270,146$6,627,0003.42%
Perceptive Advisors 1,704,330$39,506,0001.50%
Birchview Capital, LP 38,000$932,0000.88%
SECTORAL ASSET MANAGEMENT INC 229,978$5,641,0000.77%
BVF INC/IL 200,500$4,918,0000.64%
Artal Group S.A. 500,000$12,265,0000.45%
PA Capital LLC 14,692$360,0000.38%
Chicago Capital, LLC 180,911$4,438,0000.36%
TPG Group Holdings (SBS) Advisors, Inc. 716,381$17,573,0000.28%
Fosun International Ltd 197,005$4,492,0000.27%
View complete list of ALBIREO PHARMA INC shareholders